Diagnosis, prevention and management of infectious respiratory diseases

Thematic Poster
Chairs: B. Bonnesen Bertelsen (Hellerup, Denmark), H. Park (Seoul, Republic of Korea)

Predictors of severe COVID-19 among patients with uncontrolled asthma: a register- based study S. Selberg (Umeå, Sweden), J. Karlsson Sundbaum (Luleå, Sweden), J. R. Konradsen (Stockholm, Sweden), H. Backman (Umeå, Sweden), L. Hedman (Umeå, Sweden), A. Lindberg (Umeå, Sweden), C. Stridsman (Umeå, Sweden)
Symptoms persisting after hospitalization for COVID-19: 12 months interim results of the CO-FLOW study L. Bek (Rotterdam, Netherlands), J. Berentschot (Rotterdam, Netherlands), M. Heijenbrok-Kal (Rotterdam, Netherlands), G. Ribbers (Rotterdam, Netherlands), J. Aerts (Rotterdam, Netherlands), R. Van Den Berg-Emons (Rotterdam, Netherlands), M. Hellemons (Rotterdam, Netherlands)
COVID-19 infection in children through lung radiographic imaging changes O. Munteanu (Chi?inau (Chi?inau), Republic of Moldova), A. Goloborodico (Chi?inau, Republic of Moldova), R. Selevestru (Chi?inau, Republic of Moldova), D. Rotaru-Cojocari (Chi?inau, Republic of Moldova), C. Conica (Chi?inau, Republic of Moldova), S. Sciuca (Chi?inau, Republic of Moldova)
A fast point-of-care PCR test for infectious diseases, based on aerosol capturing. B. Verbruggen (Leuven, Belgium), J. Raymenants (Leuven, Belgium), T. Stakenborg (Leuven, Belgium), F. Paeps (Leuven, Belgium), E. Marchal (Leuven, Belgium), A. Jauregui Uribe (Leuven, Belgium), W. Duthoo (Leuven, Belgium), A. Kossarev (Leuven, Belgium), T. Dam (Leuven, Belgium), Y. El Jerrari (Leuven, Belgium), R. Sergio Wiederkehr (Leuven, Belgium), Z. Luo (Leuven, Belgium), M. Peca (Leuven, Belgium), L. Mcrea (Leuven, Belgium), A. Darriba Frederiks (Leuven, Belgium), A. Yurt (Leuven, Belgium), K. Ongena (Leuven, Belgium), R. Hanifa (Leuven, Belgium), J. Van Duppen (Leuven, Belgium), S. El Mahmoudi (Leuven, Belgium), M. Humbert (Leuven, Belgium), E. Emmen (Leuven, Belgium), B. Jones (Leuven, Belgium), A. Taher (Leuven, Belgium), A. Lambrechts (Leuven, Belgium), E. André (Leuven, Belgium), P. Peumans (Leuven, Belgium)
Covid-19 in children: disease spectrum and risk factors E. Mancino (Roma (RM), Italy), R. Nenna (Roma (RM), Italy), G. Di Mattia (Roma (RM), Italy), L. Matera (Roma (RM), Italy), L. Petrarca (Roma (RM), Italy), M. Conti (Roma (RM), Italy), A. Frassanito (Roma (RM), Italy), D. La Regina (Roma (RM), Italy), E. Iovine (Roma (RM), Italy), V. Fabrizio (Roma (RM), Italy), M. Spatuzzo (Roma (RM), Italy), S. Ialongo (Roma (RM), Italy), F. Bonci (Roma (RM), Italy), F. Midulla (Roma (RM), Italy)
One-year dynamics of antibody titers after three doses of SARS-CoV-2 BNT162b2 vaccine A. Breslavsky (Ashkelon, Israel), A. Bar-Shai (Tel Aviv, Israel), N. Bilenko (Beer-Sheva, Israel), O. Wand (Ashkelon, Israel)
Acute Lower Respiratory Tract Disease (aLRTD) is a complex clinical syndrome causing significant disease burden in a prospective cohort study C. Hyams (Bristol, United Kingdom), E. Begier (New York, United States), J. Southern (Tadworth, United Kingdom), J. King (Bristol, United Kingdom), A. Morley (Bristol, United Kingdom), Z. Szasz-Benczur (Bristol, United Kingdom), M. Garcia Gonzalez (Bristol, United Kingdom), J. Kinney (Bristol, United Kingdom), J. Campling (Tadworth, United Kingdom), S. Gray (New York, United States), J. Oliver (Bristol, United Kingdom), R. Hubler (New York, United States), S. Valluri (New York, United States), A. Vyse (Tadworth, United Kingdom), G. Ellsbury (Tadworth, United Kingdom), J. Mclaughlin (New York, United States), B. Gessner (New York, United States), A. Finn (Bristol, United Kingdom)
Trends in influenza vaccination rates in subjects with airflow limitation: The Korean National Health and Nutrition Examination Survey (KNHANES) 2007–2018 Y. Jo (Seoul, Republic of Korea), H. Lee (Seoul, Republic of Korea), H. Choi (Seoul, Republic of Korea)
Standardized 3- and 12-months imaging and clinical-functional pulmonary follow-up in patients hospitalized for COVID-19 D. CHIMERA (Pisa, Italy), F. Pistelli (Pisa, Italy), L. Tavanti (Pisa, Italy), G. Manfredini (Pisa, Italy), C. Romei (Pisa, Italy), A. De Liperi (Pisa, Italy), F. Aquilini (Pisa, Italy), M. Micheli (Pisa, Italy), A. Celi (Pisa, Italy), R. Pancani (Pisa, Italy), M. Desideri (Pisa, Italy), N. Carpenè (Pisa, Italy), L. Gabbrielli (Pisa, Italy), L. Carrozzi (Pisa, Italy)
Correlation between post-vaccination titres of anti-Spike antibodies and protection against breakthrough SARS-CoV-2 infection in 7530 UK adults G. Vivaldi (London, United Kingdom), D. Jolliffe (London, United Kingdom), S. Faustini (Birmingham, United Kingdom), H. Holt (London, United Kingdom), M. Talaei (London, United Kingdom), F. Tydeman (London, United Kingdom), A. Richter (Birmingham, United Kingdom), S. Shaheen (London, United Kingdom), A. Martineau (London, United Kingdom)
One-year physical recovery in patients admitted to ICU and ward for COVID-19 J. Berentschot (Rotterdam, Netherlands), M. Heijenbrok-Kal (Rotterdam, Netherlands), M. Bek (Rotterdam, Netherlands), G. Ribbers (Rotterdam, Netherlands), J. Aerts (Rotterdam, Netherlands), R. Van Den Berg-Emons (Rotterdam, Netherlands), M. Hellemons (Rotterdam, Netherlands)
Trends on pneumococcal and all-cause pneumonia incidence in Catalonian adults after universal PCV13 implementation in children. A. Vila-Córcoles (tarragona, Spain), c. de diego cabanes (tarragona, Spain), E. Satué-Gracia (tarragona, Spain), O. Ochoa-Gondar (tarragona, Spain), A. Vila-Rovira (Barcelona, Spain), D. Ribas-Seguí (tarragona, Spain)
Post COVID syndrome in health care workers in Tunisia: is there any correlation withSARS-CoV-2 IgG level? A. Dallagi (tunis, Tunisia), A. Benzarti (tunis, Tunisia), M. Mjid (tunis, Tunisia), s. marzouki (tunis, Tunisia), M. Zribi (tunis, Tunisia), M. Battikh (tunis, Tunisia), I. Ismail (tunis, Tunisia), O. Grissa (tunis, Tunisia), N. Khouja (tunis, Tunisia), J. Hssinet (tunis, Tunisia), M. Sallemi (tunis, Tunisia), L. Laadhar (tunis, Tunisia), B. Dhahri (tunis, Tunisia), A. Ben Jemaa (tunis, Tunisia)
Epidemiology analysis of bacterial co-infections in SARS-CoV-2 community-acquired pneumonia (CAP) A. Martynova (Vladivostok, Ukraine), O. Pavlova (Vladivostok, Russian Federation), S. Uskova (Vladivostok, Ukraine)
Respiratory Outcomes in COVID-19 patients 3-6 months after admission to Public Health Hospital Maciel. Montevideo, Uruguay. A Follow up Cohort Study. M. Nuñez (Montevideo, Uruguay), M. Mamchur (Montevideo, Uruguay), C. Chao (Montevideo, Uruguay), C. Rodriguez Flores (Montevideo, Uruguay), E. Pacheco (Montevideo, Uruguay), A. Tempone (Montevideo, Uruguay), K. Rabuñal (Montevideo, Uruguay), C. Silva (Montevideo, Uruguay), F. Gimenez (Montevideo, Uruguay), A. Gruss (Montevideo, Uruguay), C. Acosta (Montevideo, Uruguay), V. Iraola (Montevideo, Uruguay), M. Lopez Varela (Montevideo, Uruguay)
Recurrent community-acquired pneumonia hospitalizations: Characteristics description in a 9-year follow-up period E. Pessoa (Lisbon, Portugal), C. Bárbara (Lisbon, Portugal), A. Costa (Lisbon, Portugal), P. Nogueira (Lisbon, Portugal)
Prospective cohort study of adults hospitalised with acute COPD exacerbations: SARS-CoV-2-associated patient characteristics and clinical outcomes C. Hyams (Bristol, United Kingdom), G. Nava (Bristol, United Kingdom), E. Begier (New York, United States), J. Southern (Tadworth, United States), J. King (Bristol, United Kingdom), D. Adegbite (Bristol, United Kingdom), L. Fleming (Bristol, United Kingdom), J. Oliver (Bristol, United Kingdom), J. Nguyen (New York, United States), B. Gessner (New York, United States), J. Mclaughlin (New York, United States), A. Finn (Bristol, United Kingdom), J. Dodd (Bristol, United Kingdom)
Morbidity and mortality associated with COVID-19 patients from Luanda, Angola M. Lopes Teixeira Arrais (Luanda, Angola), W. Dias (Luanda, Angola), M. Silva (Luanda, Angola), L. Neto (Luanda, Angola), N. Pedro (Luanda, Angola), S. Jungo (Luanda, Angola), A. Miguel (Luanda, Angola), E. Fortes-Gabriel (Luanda, Angola), C. S. Sebastião (Luanda, Angola), J. M.R. Gama (Covilhã, Portugal), M. Brito (Lisboa, Portugal)
Impact of the COVID-19 pandemic on Swedish asthma and COPD care C. Stridsman (Umeå , Sweden), J. Konradsen (Stockholm, Sweden), B. Hesselmar (Gothenburg, Sweden), A. Lindberg (Umeå, Sweden), L. Vanfleteren (Umeå, Sweden)